Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Microbial lysozyme for use in the treatment of irritable bowel syndrome or inflammatory bowel disease

Microbial lysozyme for use in the treatment of irritable bowel syndrome or inflammatory bowel disease

US Patent 11179447 · Granted Nov 23, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bacillus strains improving health and performance of production animals2025
Animal feed compositions and uses thereof2025
Polypeptides having lysozyme activity, polynucleotides encoding same and uses an2025
Microbial lysozyme for use in the treatment of irritable bowel syndrome or infla2024
Microbial lysozyme for use in the treatment of irritable bowel syndrome or infla2024
Microbial lysozyme for use in the treatment of irritable bowel syndrome or infla2024
Probiotic supplement for metabolic health2024
Polypeptides having lysozyme activity, polynucleotides encoding same and uses an2024
Polypeptides having lysozyme activity, polynucleotides encoding same and uses an2024
Bacillus strains improving health and performance of production animals2023
Bacillus subtilis subspecies2022
Bacillus strains improving health and performance of production animals2022